Improving Acute Otitis Media Outcomes Through Proper Antibiotic Use and Adherence

American Journal of Managed Care

Volumn 11, Issue 6 SUPPL., 2005, Pages

  Brixner, Diana I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ACUTE DISEASE; ADOLESCENT; ARTICLE; CHILD; ECONOMICS; HUMAN; INFANT; NEWBORN; OTITIS MEDIA; PATIENT COMPLIANCE; PRESCHOOL CHILD; TREATMENT OUTCOME; UNITED STATES;

ACUTE DISEASE; ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; OTITIS MEDIA; PATIENT COMPLIANCE; TREATMENT OUTCOME; UNITED STATES;

EID: 32944468926     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Pichichero M. Evolving shifts in otitis media pathogens: relevance to a managed care organization. Am J Manag Care. 2005; 11 (suppl 6): S192-S201.
2. BranthwaiteA,PechereJC.Pan-Europeansurveyofpatients'attitudes- antibioticsandantibioticuse.JIntMedRes1996;24:229-238.(Pubitemid26168233)
3. Harrison CJ, Belhorn TH. Antibiotic treatment failures in acute otitis media. Pediatr Ann. 1991; 20: 600-608.
4. Wandstrat TL, Kaplan B. Pharmacoeeconomic impact of factors affecting compliance with antibiotic regimens in the treatment of acute otitis media. Pediatr Infect Dis J 1997; 16(2 suppl): S27-S29. (Pubitemid 27078815)
5. PichicheroMEReinerSA,BrookI,etal. Controversiesinthemedicalmanagementofpersistentandrecurrentacuteotitismedia. Recommendationsofaclinicaadvisorycommittee.AnnOtolRhinolLaryngolSuppl.2000;183: 1-12.(Pubitemid30637021)
6. PichicheroMEAcuteotitismedia:partII. Treatmentinaneraofincreasingantibioticresistance.AmFamPhysician.2000;61: 2410-2416.(Pubitemid30243968)
7. Block SL, Harrison CJ. Diagnosis and Management of Acute Otitis Media. New York: Professional Communications; 2001.
8. Marcy M, Takata G, Shekelle P, et al. Management of Acute Otitis Media. Evidence Report/Technology Assessment No.15 (Prepared by the Southern California Evidence-based Practice Center under Contract No. 290-97-0001). AHRQ Publication No. 01-E010. Rockville, Md: Agency for Healthcare Research and Quality; 2001.
9. Bondy J, Berman S, Glazner J, Lezotte D. Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric Medicaid cohort. Pediatrics. 2000; 105: E72.
10. BermanS,RoarkR,LuckeyD. Theoreticalcosteffectivenessofmanagementoptionsforchildrenwithperastingmiddle eareffusions.Pediatrics1994;93:353-363.(Pubitemid24067003)
11. Gates GA. Cost-effectiveness considerations in otitis media treatment. Otolaryngol Head Neck Surg. 1996; 114: 525-530. (Pubitemid 26114246)
12. Stool SE, Field MJ. The impact of otitis media Pediatr Infect Dis J 1989; 8(1 suppl): S11-S14.
13. ISPOR Lexicon. 1st ed. Princeton, NJ International Society for Pharmacoeconomics and Outcomes Research; 1998.
14. Adolf BP. Life cycle benefits. Enpl Benefits J. 1993; 18: 13-20.
15. Liston SL. Socioeconomics and otitis media. Pediatrics 2004; 114: 898-899.
16. Carabin H, Gyorkos TW, Soto JC, et al. Estimation of direct and indirect costs because of common infections in toddlers attending day care centers. Pediatrics. 1999; 103: 556-564. (Pubitemid 29274500)
17. Cifaldi MA, Paris MM, Devcich KJ, Bukofzer S Parent-reported outcomes for treatment of acute otitis media with cefdinir or amoxicillin/clavulanate ora suspensions. Paediatr Drugs 2004; 6: 387-393. (Pubitemid 40065381)
18. Greenberg D, Bilenko N, Liss Z, et al. The burden of acute otitis media on the patient and the family. Eur J Pediatr. 2003; 162: 576-581. (Pubitemid 37100616)
19. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physiciansin the United Sates JIMA 1995; 273: 214-219.
20. Wald ER, Dashefsky B, Byers C, Guerra N, Taylor F. Frequency and severity of infections in day care. J Pediatr. 1988; 112: 540-546.
21. Wald ER, Guerra N, Byers C. Frequency and severity of infections in day care: three-year follow-up. J Pediatr. 1991; 118: 509-514.
22. Marx J, Osguthorpe JD, Parsons G. Day care and the incidence of otitis media in young children. Otolaryngol Head Neck Surg. 1995; 112: 695-699.
23. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002; 287: 3096-3102.
24. Palmer DA, Bauchner H. Parents' and physicians' views on antibiotics Pediatrics. 1997; 99: E6.
25. Capra AM, Lieu TA, Black SB, et al. Costs of otitis media in a managed care population. Pediatr Infect Dis J 2000; 19: 354-355.
26. Teele DW, Klein JD, Chase C, Menyuk P, Rosner BA. Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years. Greater Boston Otitis Media Sudy Group. J Infect Dis. 1990; 162: 685-694.
27. Paradise JL, Haggard MP, Lous J, Roberts JE, Schilder AG. Developmental implications of early-life otitis media. Int JPediatr Otorhinolaryngol. 1995; 32 (suppl): S37-S44.
28. BauchnerH,KleinJO. Parentaissuesinselectionofantimicrobialagentsforinfantsandchildren. ClinPediatr(Phila).1997;36:201-205.(Pubitemid27172605)
29. McCracken GH Jr. Treatment of acute otitis media in an era of increasing microbial resistance. Pediatr Infect Dis J 1998; 17: 576-579.
30. Block SL, Busman TA, Paris MM, Bukofzer S. Comparison of five-day cefdinir treatment with ten-day low dose amoxicillin/clavulanate treatment for acute otitis media Pediatr Infect Dis J 2004; 23: 834-838. (Pubitemid 40221026)
31. Arrieta A, Arguedas A, Fernandez P, et al. Highdose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or perastent acute otitis media. Antimicrob Agents Chemother. 2003; 47: 3179-3186. (Pubitemid 37229576)
32. Block SL, Busman TA, Kapral D, Cifaldi MA, Paris MM. Cefdinir twice-daily demonstrated similar efficacy, satisfaction, ease of use and compliance when compared with azithromycin once-daily in the treatment of acute otitis media. Abstract presented at: 6th European Congress of Chemotherapy and Infection Meeeting; December 1-3, 2004; Paris France; Abstract.
33. American Academy of Pediatrics Subcommittee on Management. Diagnosis and management of acute otitis media. Pediatrics 2004; 113: 1451-1465.
34. Davey P, Parker S. Cost effectiveness of once-daily oral antimicrobial therapy. J Clin Pharmacol. 1992; 32: 706-710.
35. PetersonAM,TakiyaL,FinleyRMeta-analyasisoftrialsofinterventions- improvemedicationadherence.AmJHealthSystPharm.2003;60:657-665. (Pubitemid36752868)
36. Pichichero ME, Cohen R. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis. Pediatr Infect Dis J 1997; 16: 680-695. (Pubitemid 27300707)
37. Howie VM. Eradication of bacteria pathogens from middle ear infections. Clin Infect Dis 1992; 14(suppl 2): 209-211.
38. Steele RW, Thomas MP, Begue RE Compliance issues related to the selection of antibiotic suspensions for children. Pediatr Infect Dis J 2001; 20: 1-5.
39. Demers DM, Chan DS, Bass JW. Antimicrobial drug suspensions: a blinded comparison of taste of twelve common pediatric drugs including cefixime, cefpodoxime, cefprozil and loracarbef. Pediatr Infect Dis J 1994; 13: 87-89.
40. EI Chaar GM, Mardy G, Wehlou K, Rubin LG. Randomized, double blind comparison of brand and generic antibiotic suspendons: II. A study of taste and compliance in children. Pediatr Infect Dis J 1996; 15: 18-22. (Pubitemid 26029239)
41. SjovallJ,FoghA,HuitfeldtB,KarlssonG,NylenO. Methodsforevaluatingthetasteofpaediatricformulationsinchildren: acomparisonbetweenthefacialhedonicmethodandthepatients'ownspontaneousverbaljud gement.EurJPediatr.1984;141:243-247.(Pubitemid14193912)
42. UhariM,EskelinenL, JbkisaloJAcceptanceofantibioticmixturesbyinfantsandchildren.EirJClinPharmacol. 1986;30:503-504.(Pubitemid16088216)
43. MatsuiD,LimR,TschenT,RiederMJ.Assessmentofthepalatabilityofbeta- lactamase-resistantantibioticsinchildren.ArchPediatrAdolescMed.1997;151:599-602. (Pubitemid27262286)
44. MatsuiD,BarronA,RiederMJ. Assessmentofthepalatabilityofantistaphylococcalantibioticsinpediatricvolunteers. AnnPharmacother.1996;30:586-588.(Pubitemid26184408)
45. AngelilliML,ToscaniM,MatsuiDM,RiederMJ. Palatabilityoforalantibioticsamongchildreninanurbanprimarycarecenter. ArchPediatrAdolescMed.2000;154:267-270.(Pubitemid30131908)
46. Powers JL, Gooch WM, III, Oddo LP. Comparison of the palatability of the oral suspension of cefdinir vs amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients. Pediatr Infect Dis J 2000;19(12 suppl): S174-S180.
47. Steele RW, Blumer JL, Kalish GH. Patient, physician, and nurse satisfaction with antibiotica Clin Pediatr (Phila). 2002; 41: 285-299.
48. BauchnerH,AdamsW,BarnettE,KleinJTherapyforacuteotitismedia. Preferenceofparentsfororalorparenteralantibiotic.ArchPediatrAdolescMed.1996;150: 396-399.(Pubitemid26109222)
49. KennedyJ,ErbC.Prescriptionnoncompliancedue- costamongadultswithdisabilitiesintheUnitedSates.AmJPublicHeath.2002;92: 1120-1124.(Pubitemid34700978)
50. Rette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004; 27: 384-391. (Pubitemid 38174062)
51. Rector TS, Venus PJ. Do drug benefits help Medicare beneficiaries afford prescribed drugs? Health Aff (Millwood). 2004; 23: 213-222.
52. Strickland WJ, Hanson CM. Coping with the cost of prescription drugs. J Health Care Poor Underserved. 1996; 7: 50-62.
53. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Sreptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999; 18: 1-9.